New ALS drug headed for phase II trial
Sunday, October 27, 2013 - 20:00
in Health & Medicine
Researchers will soon begin phase IIa clinical trials of TDI-132, a drug that in animal models has shown promise in reducing the inflammation associated with Amyotrophic Lateral Sclerosis.